Improving Human Papilloma Virus Vaccination Rates: Quality Improvement

BACKGROUND: Human papilloma virus (HPV) is a sexually transmitted infection with a national prevalence of greater than 70 million. Most infections are among persons 15–24 years of age. The HPV vaccine has nearly 100% efficacy when administered before natural exposure. However, national vaccination r...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowden, Michelle, Yaun, Jason, Bagga, Bindiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Individual QI Projects from Single Institutions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132894/
https://www.ncbi.nlm.nih.gov/pubmed/30229184
http://dx.doi.org/10.1097/pq9.0000000000000048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132894/
https://www.ncbi.nlm.nih.gov/pubmed/30229184
http://dx.doi.org/10.1097/pq9.0000000000000048

Ejemplares similares